Simpson EL, Merola JF, Silverberg JI, Reich K, et al. Safety of Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-blind, Placebo-controlled Phase 2 and Phase 3 Trials. Br J Dermatol 2022 Sep 9. doi: 10.1111/bjd.21867.
PMID: 36082590